Diégina Araújo Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diégina Araújo Fernandes has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Maria de Fátima Vanderlei de Souza
Post Graduation Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa, Brazil
9 shared publications - Gilda Guimarães Leitão
Instituto de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil
6 shared publications - Suzana Guimarães Leitão
Departamento de Produtos Naturais e Alimentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
6 shared publications - Yanna Carolina Ferreira Teles
Universidade Federal da Paraíba
6 shared publications - Brendo Araujo Gomes
Programa de Pós-Graduação em Biotecnologia Vegetal, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
5 shared publications - Fabiola C. Nunes
Universidade Federal da Paraíba, Brazil
4 shared publications
Latest Publications
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Macropetalin, a Natural Alkamide, and Other Compounds from the Aerial Parts of Helicteres macropetala (Malvaceae) and Their in vitro Evaluation against Chikungunya Virus
The incidence of arboviruses transmitted by Aedes spp. represents a major public health challenge, particularly in regions with inadequate prevention and sanitation. In this context, Helicteres species are promising sources of antivirals due to their ethnopharmacological background. Among them, Helicteres macropetala A. St.-Hil. (Malvaceae, “saca-rolha”) remains poorly investigated phytochemical and biologically. This study aimed to characterize H. macropetala chemical constituents and evaluate the antiviral potential of extract, fractions, and isolated compounds against Chikungunya virus (CHIKV). The crude ethanolic extract obtained from the aerial parts was partitioned into hexane, dichloromethane, chloroform, ethyl acetate, n-butanol, and hydroalcoholic phases, followed by chromatographic fractionation. Fifteen compounds were isolated and identified, including aliphatic alcohols, steroids, triterpenes, pheophytin, quinone, phenolic compounds, and alkamides. Among these, three long-chain alcohols and the alkamide N-trans-caffeoyltyramine were reported for the first time in the genus Helicteres, while another alkamide, macropetalin, was isolated from a natural source for the first time. Macropetalin [N-(3”,4”-dihydroxybenzyl)-3-(3,4-dihydroxyphenyl)acrylamide] was characterized, marking its first reported isolation from a natural source. Among the isolated compounds evaluated for CHIKV replicon inhibition, mansonone H showed the highest activity, inhibiting replication by 62.2 ± 3.1% and markedly reducing enhanced green fluorescent protein (EGFP) expression. These findings suggest that H. macropetala is promising source of compounds capable of interfering with CHIKV replication and identify mansonone H as a promising inhibitor of BHK-21-CHIKV‑NCT replicon activity.
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Macropetalin, a Natural Alkamide, and Other Compounds from the Aerial Parts of Helicteres macropetala (Malvaceae) and Their in vitro Evaluation against Chikungunya Virus
The incidence of arboviruses transmitted by Aedes spp. represents a major public health challenge, particularly in regions with inadequate prevention and sanitation. In this context, Helicteres species are promising sources of antivirals due to their ethnopharmacological background. Among them, Helicteres macropetala A. St.-Hil. (Malvaceae, “saca-rolha”) remains poorly investigated phytochemical and biologically. This study aimed to characterize H. macropetala chemical constituents and evaluate the antiviral potential of extract, fractions, and isolated compounds against Chikungunya virus (CHIKV). The crude ethanolic extract obtained from the aerial parts was partitioned into hexane, dichloromethane, chloroform, ethyl acetate, n-butanol, and hydroalcoholic phases, followed by chromatographic fractionation. Fifteen compounds were isolated and identified, including aliphatic alcohols, steroids, triterpenes, pheophytin, quinone, phenolic compounds, and alkamides. Among these, three long-chain alcohols and the alkamide N-trans-caffeoyltyramine were reported for the first time in the genus Helicteres, while another alkamide, macropetalin, was isolated from a natural source for the first time. Macropetalin [N-(3”,4”-dihydroxybenzyl)-3-(3,4-dihydroxyphenyl)acrylamide] was characterized, marking its first reported isolation from a natural source. Among the isolated compounds evaluated for CHIKV replicon inhibition, mansonone H showed the highest activity, inhibiting replication by 62.2 ± 3.1% and markedly reducing enhanced green fluorescent protein (EGFP) expression. These findings suggest that H. macropetala is promising source of compounds capable of interfering with CHIKV replication and identify mansonone H as a promising inhibitor of BHK-21-CHIKV‑NCT replicon activity.
- Open Access
- 12 November 2025
- Published by MDPI AG in Preprints.org
“Sweet and Horny”: Biological Activities of the Annonaceae Family
Natural products are sources of secondary metabolites with various biological activities. This review highlights the promising potential of the Annonaceae family, a large clade of flowering plants with 107 genera and over 2300 species. Known for their vast pharmacological activities, several genera and species within this family are considered excellent sources of bioactive molecules due to the diversity of their secondary metabolites. Chemical investigations have revealed the presence of alkaloids, mainly isoquinolinic alkaloids, phenolic compounds, terpenoids, lactones, and acetogenins. The Annonaceae family exhibits anti-inflammatory, insecticidal, antimicrobial, leishmanicidal, cytotoxic, antitumor, trypanocidal, antioxidant, gastroprotective, and antimalarial activities. However, most studies focus on plant extracts and essential oils, with few isolated molecules and mechanisms of action identified. Investigating the biological activity of isolated compounds is crucial for new drug discovery. This review also compiles important information for the pharmaceutical and agricultural industries.
- 12 November 2025
- Published by MDPI AG in Preprints.org
Open Access“Sweet and Horny”: Biological Activities of the Annonaceae Family
Natural products are sources of secondary metabolites with various biological activities. This review highlights the promising potential of the Annonaceae family, a large clade of flowering plants with 107 genera and over 2300 species. Known for their vast pharmacological activities, several genera and species within this family are considered excellent sources of bioactive molecules due to the diversity of their secondary metabolites. Chemical investigations have revealed the presence of alkaloids, mainly isoquinolinic alkaloids, phenolic compounds, terpenoids, lactones, and acetogenins. The Annonaceae family exhibits anti-inflammatory, insecticidal, antimicrobial, leishmanicidal, cytotoxic, antitumor, trypanocidal, antioxidant, gastroprotective, and antimalarial activities. However, most studies focus on plant extracts and essential oils, with few isolated molecules and mechanisms of action identified. Investigating the biological activity of isolated compounds is crucial for new drug discovery. This review also compiles important information for the pharmaceutical and agricultural industries.
- 2 November 2025
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 37 (6) , 409-427
Mono- and sesquiterpenes from Protium species (Burseraceae) as SARS-CoV-2 target inhibitors: a systematic review and ADMETox analysis
- 2 November 2025
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 37 (6) , 409-427
Mono- and sesquiterpenes from Protium species (Burseraceae) as SARS-CoV-2 target inhibitors: a systematic review and ADMETox analysis
- Open Access
- 14 June 2025
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 4 (2) , 27
Plants Metabolites as In Vitro Inhibitors of SARS-CoV-2 Targets: A Systematic Review and Computational Analysis
Background/Objectives: Since the emergence of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the discovery of compounds with antiviral potential from medicinal plants has been extensively researched. This study aimed to investigate plant metabolites with in vitro inhibitory potential against SARS-CoV-2 targets, including 3CLpro, PLpro, Spike protein, and RdRp. Methods: A systematic review was conducted following PRISMA guidelines, with literature searches performed in six electronic databases (Scielo, ScienceDirect, Scopus, Springer, Web of Science, and PubMed) from January 2020 to February 2024. Computational analyses using SwissADME, pkCSM, ADMETlab, ProTox3, Toxtree, and DataWarrior were performed to predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles as well as other medicinal chemistry parameters of these compounds. Results: A total of 330 plant-derived compounds with inhibitory activities against the proposed targets were identified, with compounds showing IC50 values as low as 0.01 μM. Our findings suggest that several plant metabolites exhibit significant in vitro inhibition of SARS-CoV-2 targets; however, few molecules exhibit drug development viability without further adjustments. Additionally, after these evaluations, two phenolic acids, salvianic acid A and protocatechuic acid methyl ester, stood out for their potential as candidates for developing antiviral therapies, with IC50 values of 2.15 μM against 3CLpro and 3.76 μM against PLpro; respectively; and satisfactory in silico drug-likeness and ADMET profiles. Conclusions: These results reinforce the importance of plant metabolites as potential targets for antiviral drug discovery.
- 14 June 2025
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 4 (2) , 27
Open AccessPlants Metabolites as In Vitro Inhibitors of SARS-CoV-2 Targets: A Systematic Review and Computational Analysis
Background/Objectives: Since the emergence of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the discovery of compounds with antiviral potential from medicinal plants has been extensively researched. This study aimed to investigate plant metabolites with in vitro inhibitory potential against SARS-CoV-2 targets, including 3CLpro, PLpro, Spike protein, and RdRp. Methods: A systematic review was conducted following PRISMA guidelines, with literature searches performed in six electronic databases (Scielo, ScienceDirect, Scopus, Springer, Web of Science, and PubMed) from January 2020 to February 2024. Computational analyses using SwissADME, pkCSM, ADMETlab, ProTox3, Toxtree, and DataWarrior were performed to predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles as well as other medicinal chemistry parameters of these compounds. Results: A total of 330 plant-derived compounds with inhibitory activities against the proposed targets were identified, with compounds showing IC50 values as low as 0.01 μM. Our findings suggest that several plant metabolites exhibit significant in vitro inhibition of SARS-CoV-2 targets; however, few molecules exhibit drug development viability without further adjustments. Additionally, after these evaluations, two phenolic acids, salvianic acid A and protocatechuic acid methyl ester, stood out for their potential as candidates for developing antiviral therapies, with IC50 values of 2.15 μM against 3CLpro and 3.76 μM against PLpro; respectively; and satisfactory in silico drug-likeness and ADMET profiles. Conclusions: These results reinforce the importance of plant metabolites as potential targets for antiviral drug discovery.
- Open Access
- 13 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 633
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
The COVID-19 pandemic has caused over 7 million deaths globally in the past four years. Siparuna spp. (Siparunaceae), which is used in Brazilian folk medicine, is considered a genus with potential antiviral alternatives. This study explored the correlation between phytochemicals in Siparuna leaf extracts (S. ficoides, S. decipiens, S. glycycarpa, S. reginae, and S. cymosa) and their potential against various SARS-CoV-2 targets. In vitro assays examined interactions between the spike protein and the ACE2 receptor, protease activity, and viral replication inhibition in Calu-3 cell models. UHPLC-MS/MS analysis, processed with MZmine and evaluated chemometrically, revealed isoquinoline alkaloids with bulbocapnine, showing promising therapeutic potential. Predictions regarding absorption, distribution, metabolism, excretion, and toxicity were conducted, along with molecular docking and dynamics simulations, to evaluate protein−ligand interaction stability. The results confirmed the antiviral activity of the Siparuna genus against SARS-CoV-2 targets, with 92% of the extracts maintaining over 70% cellular viability at 200 μg·mL−1 and 80% achieving more than 50% viral activity suppression at 50 μg·mL−1. These findings highlight the potential of isoquinoline alkaloids as novel anti-coronavirus agents and support the need for further exploration, isolation, and testing of Siparuna compounds in the fight against COVID-19.
- 13 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 633
Open AccessPredicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
The COVID-19 pandemic has caused over 7 million deaths globally in the past four years. Siparuna spp. (Siparunaceae), which is used in Brazilian folk medicine, is considered a genus with potential antiviral alternatives. This study explored the correlation between phytochemicals in Siparuna leaf extracts (S. ficoides, S. decipiens, S. glycycarpa, S. reginae, and S. cymosa) and their potential against various SARS-CoV-2 targets. In vitro assays examined interactions between the spike protein and the ACE2 receptor, protease activity, and viral replication inhibition in Calu-3 cell models. UHPLC-MS/MS analysis, processed with MZmine and evaluated chemometrically, revealed isoquinoline alkaloids with bulbocapnine, showing promising therapeutic potential. Predictions regarding absorption, distribution, metabolism, excretion, and toxicity were conducted, along with molecular docking and dynamics simulations, to evaluate protein−ligand interaction stability. The results confirmed the antiviral activity of the Siparuna genus against SARS-CoV-2 targets, with 92% of the extracts maintaining over 70% cellular viability at 200 μg·mL−1 and 80% achieving more than 50% viral activity suppression at 50 μg·mL−1. These findings highlight the potential of isoquinoline alkaloids as novel anti-coronavirus agents and support the need for further exploration, isolation, and testing of Siparuna compounds in the fight against COVID-19.
- 1 August 2024
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 31 (26) , 4138-4159
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach
Background: Thrombosis is one of the major causes of morbidity and mortality in a wide range of vessel diseases. Several studies have been conducted to identify antithrombotic agents from medicinal plants, and phenolic compounds (PCs) have been shown to effectively inhibit plasma coagulation and platelet aggregation. Objectives: This study aimed to conduct a survey of the natural PCs with proven antithrombotic and antiplatelet activities, as well as to evaluate by computational modeling the physicochemical and toxicological properties of these compounds using drug-likeness approaches. Methods: The data were collected from the scientific database: ‘Web of Science’, ‘Scifinder’, ‘Pubmed’, ‘ScienceDirect’ and ‘Google Scholar’, the different classes of PCs with antithrombotic or antiplatelet effects were used as keywords. These molecules were also evaluated for their Drug-Likeness properties and toxicity to verify their profile for being candidates for new antithrombotic drugs. Results: In this review, it was possible to register 85 lignans, 73 flavonoids, 28 coumarins, 21 quinones, 23 phenolic acids, 8 xanthones and 8 simple phenols. Activity records for tannins were not found in the researched databases. Of these 246 compounds, 213 did not violate any of Lipinski's rules of five, of which 125 (59%) showed non-toxicity, being promising candidates for new potential antithrombotic drugs. Conclusion: This review arouses interest in the isolation of phenolic compounds that may allow a new approach for the prevention of both arterial and venous thrombosis, with the potential to become alternatives in the prevention and treatment of cardiovascular diseases.
- 1 August 2024
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 31 (26) , 4138-4159
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach
Background: Thrombosis is one of the major causes of morbidity and mortality in a wide range of vessel diseases. Several studies have been conducted to identify antithrombotic agents from medicinal plants, and phenolic compounds (PCs) have been shown to effectively inhibit plasma coagulation and platelet aggregation. Objectives: This study aimed to conduct a survey of the natural PCs with proven antithrombotic and antiplatelet activities, as well as to evaluate by computational modeling the physicochemical and toxicological properties of these compounds using drug-likeness approaches. Methods: The data were collected from the scientific database: ‘Web of Science’, ‘Scifinder’, ‘Pubmed’, ‘ScienceDirect’ and ‘Google Scholar’, the different classes of PCs with antithrombotic or antiplatelet effects were used as keywords. These molecules were also evaluated for their Drug-Likeness properties and toxicity to verify their profile for being candidates for new antithrombotic drugs. Results: In this review, it was possible to register 85 lignans, 73 flavonoids, 28 coumarins, 21 quinones, 23 phenolic acids, 8 xanthones and 8 simple phenols. Activity records for tannins were not found in the researched databases. Of these 246 compounds, 213 did not violate any of Lipinski's rules of five, of which 125 (59%) showed non-toxicity, being promising candidates for new potential antithrombotic drugs. Conclusion: This review arouses interest in the isolation of phenolic compounds that may allow a new approach for the prevention of both arterial and venous thrombosis, with the potential to become alternatives in the prevention and treatment of cardiovascular diseases.
- 8 April 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (5) , 883-898
Brazilian Medicinal Plants and Their Metabolites as Potential Antivirals Against SARS-CoV-2: a Systematic Review of Experimental Findings
- 8 April 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (5) , 883-898
Brazilian Medicinal Plants and Their Metabolites as Potential Antivirals Against SARS-CoV-2: a Systematic Review of Experimental Findings
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 83, e244127
Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6”-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay
Tiliroside is a glycosidic flavonoid present in many plants species including Helicteres velutina K. Schum (Malvaceae sensu lato), commonly known in Brazil as “pitó”. This molecule has been shown to have many biological activities, however no study has been carried out to investigate the toxicity of this substance. The present work aimed to evaluate the possible cellular toxicity in silico, in vitro and ex-vivo of the kaempferol-3-O-β-D-(6”-E-p-coumaroyl) glucopyranoside (tiliroside), through chemical structure analysis, toxicity assessment and predictive bioactive properties, using human samples for in vitro and ex-vivo tests. The in silico analysis suggests that tiliroside exhibited great absorption index when penetrating biological membranes. In addition, it also displayed considerable potential for cellular protection against free radicals, and anticarcinogenic, antioxidant, antineoplastic, anti-inflammatory, anti-hemorrhagic and antithrombotic activities. The assessment of the hemolytic and genotoxic effects of tiliroside showed low hemolysis rates in red blood cells and absence of cellular toxicity in the oral mucosa cells. The data obtained indicate that this molecule could be a promising therapeutic approach as a possible new drug with biotechnological potential.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 83, e244127
Open AccessAnalysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6”-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay
Tiliroside is a glycosidic flavonoid present in many plants species including Helicteres velutina K. Schum (Malvaceae sensu lato), commonly known in Brazil as “pitó”. This molecule has been shown to have many biological activities, however no study has been carried out to investigate the toxicity of this substance. The present work aimed to evaluate the possible cellular toxicity in silico, in vitro and ex-vivo of the kaempferol-3-O-β-D-(6”-E-p-coumaroyl) glucopyranoside (tiliroside), through chemical structure analysis, toxicity assessment and predictive bioactive properties, using human samples for in vitro and ex-vivo tests. The in silico analysis suggests that tiliroside exhibited great absorption index when penetrating biological membranes. In addition, it also displayed considerable potential for cellular protection against free radicals, and anticarcinogenic, antioxidant, antineoplastic, anti-inflammatory, anti-hemorrhagic and antithrombotic activities. The assessment of the hemolytic and genotoxic effects of tiliroside showed low hemolysis rates in red blood cells and absence of cellular toxicity in the oral mucosa cells. The data obtained indicate that this molecule could be a promising therapeutic approach as a possible new drug with biotechnological potential.
- 1 July 2021
- Published by Editora e-Publicar
- p. 541-558
INOVAÇÃO E PATENTES NO BRASIL: UMA ABORDAGEM COM ENFOQUE NO SETOR QUÍMICO
Organizadores: Rafael Leal da Silva e Roger Goulart Mello
- 1 July 2021
- Published by Editora e-Publicar
- p. 541-558
INOVAÇÃO E PATENTES NO BRASIL: UMA ABORDAGEM COM ENFOQUE NO SETOR QUÍMICO
Organizadores: Rafael Leal da Silva e Roger Goulart Mello